This is a Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow
Clinical Trial Grant
Awarded By
Cytokinetics, Inc.
Start Date
May 22, 2020
End Date
March 31, 2024
Awarded By
Cytokinetics, Inc.
Start Date
May 22, 2020
End Date
March 31, 2024